https://www.foxbusiness.com/markets/alliance-pharma-says-unlikely-to-regain-full-market-share-for-immucyst
Alliance Pharma says unlikely to regain full market share for ImmuCyst | Fox Business
Britain's Alliance Pharma does not expect bladder cancer drug ImmuCyst to regain the 90 percent market share it held in the UK as the company gets ready to...